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Summary: The process of aging presents itself with various alterations in physiological events. Although the
turnover of catecholamines increases with aging, there is a lack of response to catecholamines in target tissues. One
of the key enzymes in catecholamine metabolism is monoamine oxidase. It has been suggested that tissue and serum
monoamine oxidase activities show pathological alterations in various diseases while physiological fluctuations can
also be detected in normals. The aim of this study is to determine the sex and age related changes of platelet and
serum monoamine oxidase in healthy volunteers.
In this study, 75 healthy volunteers of different ages (21-80 a) and sexes (40 females, 35 males) were included.
Serum and platelet monoamine oxidase determinations were performed spectrophotofluorometrically by Tufoesson's
(Scand J Clin Lab Invest 1970; 26:151-4) and Kraml's (Biochem Pharmacol 1965; 14:1684-6) modified meth-
ods, respectively.
While there was no significant difference in serum monoamine oxidase activities related to age and sex, platelet
monoamine oxidase manifested a significant increase in females compared to males (p < 0.05) and the mean values
in both sexes showed an increase with age (p < 0.001).
The results of this study imply that platelet monoamine oxidase shows an age related increase which is more
prominent in females.
Introduction
The process of aging, which has been an extensive area
of investigation during recent years, manifests itself with
various alterations in physiological events. It has been
shown that with aging, the turnover of catecholamines
increases, however, there is a lack of response to cate-
cholamines in target tissues. The increases in the activi-
ties of the enzymes involved in catecholamine metabo-
lism are held responsible for these changes (1—6).
One of the key enzymes in catecholamine metabolism is
monoamine oxidase (EC 1.4.3.4) which is an oxidore-
ductase that deaminates monoamines such as adrenaline,
noradrenaline and dopamine (7—8). There are two types
of monoamine oxidase, one being a FAD containing en-
zyme (intracellular) located in the outer membrane of
the mitochondria of many tissues such as platelets
(8—12) and the other, a Cu2+ and pyridoxal phosphate
containing enzyme found in serum (13). It has been sug-
gested that while tissue and serum monoamine oxidase
activities manifest abnormal alterations in various dis-
ease states (13—26), physiological fluctuations may also
be detected in normals (8, 27—30). The objective of this
study has been to investigate the sex and age related




In this study, conducted in the Hospital of Ege University School
of Medicine with the permission of the Ethics Committee, 75
healthy volunteers of different ages (21 —80 a) and sexes (40
females, 35 males) were included. These volunteers were taking
no medication or alcohol. They neither smoke nor suffer from
any disorder.
Reagents and solutions
All reagents were analytical grade and purchased from Sigma
Chem. Co. (St Louis) and Merck Darmstadt (Germany).
Assay
For serum monoamine oxidase determinations, 3 ml venous blood,
after coagulation, was centrifuged at 1500g for 15 minutes to ob-
tain the serum. For platelet monoamine oxidase determinations,
10 ml venous blood samples were collected in polypropylene test
tubes containing 0.5 ml of 50 g/1 Na2EDTA. For platelet isolation,
Corash's platelet isolation method modified by Glover et al. (19)
was applied. The sample was centrifuged at 3 20 g for 10 min and
the platelet-rich plasma withdrawn and re-centrifuged at 2500 g for
15 min. The platelet pellet was resuspended and washed in 1 ml of
0.15 mol/1 NaCl and re-centrifuged at 2500 g for 15 min. The pellet
was resuspended in 1 ml of 0.15 mol/1 NaCl and used for the mea-
surement of monoamine oxidase. Platelet protein concentrations
were assayed by the method of Lowry et al. (31).
Serum and platelet monoamine oxidase determinations were per-
formed spectrophotofluorometrically (with the Aminco-Bowman
spectrophotofluorometer) using Tu/vesson's (32) and Kraml's (33)
modified methods, respectively. The principle of both of these as-
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says is based on the spectrofluorometric measurement of the fluo-
rescence of 4-hydroxyquinoline formed by the oxidative deamina-
tion of kynuramine via monoamine oxidase. The amount of 4-hy-
droxyquinoline formed is directly proportional to the monoamine
oxidase activity of the sample.
Statistical analysis
For statistical analysis, variance analysis (F test-one way ANOVA)
and the Student t test were used.
Results
The mean platelet monoamine oxidase activities in dif-
ferent age groups and sexes are presented in table 1. As
Tab. 1 Platelet monoamine oxidase activities in different age
groups and sexes.





Platelet monoamine oxidase activities
(nmol/h · mg protein)
Females Males
η χ ± SD n
21-30 6 5.61 ± 1.45 6
31-40 5 5.92 ±1.11 5
41-50 10 5.29 ±1.48 5
51-60 9 7.81 ± 1.40 7
61-70 5 13.30 + 4.31 6
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Fig. 1 Age-related changes in the mean values of platelet mono-
amine oxidase activities in different age groups in both sexes.
-·- female
— Δ — male
may be observed in figure 1, mean platelet monoamine
oxidase activities increase with age (for females
ρ < 0.001, for males ρ < 0.005).
The mean platelet monoamine oxidase activity of fe-
males (8.80 ± 5.43 nmol/h · mg protein) is significantly
higher than that of males (6.18 ± 3.32 nmol/h · mg pro-
tein) (p < 0.05). The mean serum monoamine oxidase
activity is 17.27 ± 6.97 mU/1 for females, while it is
18.21 ± 7.03 mU/1 for males. Although serum mono-
amine oxidase activity is higher in males than in fe-
males, the difference is not statistically significant
(fig-2).
The results of the age-related changes in serum mono-
amine oxidase activities in both sexes are presented in
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Fig. 2 Age-related changes in the mean values of serum mono-
amine oxidase activities in different age groups in both sexes.
—·— female
— Δ — male
amine oxidase activities do not change related to age in
either females or males.
Discussion
The results of the studies investigating the age and sex
related changes in platelet and serum monoamine oxi-
dase activities reveal contradictory data. Robinson et al.
(4) in serum and platelets, Tryding et al. (26) in serum,
Murphy et al. (34) and Bagdy & Rihmer (35) in platelets
and Benedetti et al. (5) in brain tissue noted an increase
in monoamine oxidase activity with age. Meanwhile,
Baron et al. (36) in platelets and Tryding et al. (26) in
serum showed that monoamine oxidase activities were
higher in females than in males. These investigators pro-
posed that the higher activity of the enzyme in females
is the result of the interaction between female sex hor-
mones and monoamine oxidase (26, 36). However, in
concordance with our results, most of the studies assay-
ing serum monoamine oxidase activities reveal no sig-
nificant differences related to age and sex (8, 27-30).
In our study, when the relationship between platelet
monoamine oxidase activity and age was investigated, it
was seen that in correlation with Robinson's et al. (4),
Murphy's et al. (34) and Bagdy's & Rihmer's (35) find-
ings there was a significant correlation between aging
and enzyme activity. Regardless of sex, mean platelet
monoamine oxidase levels in different age groups mani-
fested a significant increase with age (p < 0.001). When
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the females and males are evaluated separately, it is ob-
served that platelet monoamine oxidase activities also
increase with age in both sexes (p < 0.001 in females
and < 0.005 in males) (fig. 1).
It is observed that in all of the age groups mean platelet
monoamine oxidase levels are higher in females than
males. This increase in females is significantly higher in
all groups (p < 0.05) except between the ages of 41 —50
and 51-60 (tab. 1). Especially, the striking increase re-
lated to monoamine oxidase in females after the age of 60
is interesting. Our findings related to monoamine oxidase
activity in females points to a possible link between fe-
male hormonal status and monoamine oxidase. However,
this link is still obscure. Previously, Holzbauer & Youdim
(37) have observed a stimulating effect of progesterone on
uterine, ovarian and adrenal monoamine oxidase activity.
The information available being incomplete, it is not pos-
sible to draw any general conclusion (4, 34, 37). Further
research in this area should be continued.
As to serum monoamine oxidase activity, no significant
correlation between enzyme activity and sex is noted.
Mean serum monoamine oxidase values are higher in
males than in females but this increase is not statistically
significant (tab. 2). Our results, related to serum mono-
amine oxidase activity, age and sex are in correlation
with the previous studies (8, 27—30).
As a result, it is concluded that platelet monoamine oxi-
dase activity increases with age, this change being more
prominent in females.
Further detailed studies revealing the interaction be-
tween platelet monoamine oxidase activity and biogenic
amine metabolism are necessary in order to elucidate the
role of biogenic amines in the process of aging.
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